Joseph B. El-Khoury, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 30 | 2020 | 1266 | 4.370 |
Why?
|
| Receptors, Scavenger | 10 | 2017 | 121 | 1.650 |
Why?
|
| Amyloid beta-Peptides | 18 | 2019 | 3587 | 1.550 |
Why?
|
| Alzheimer Disease | 16 | 2019 | 8037 | 1.140 |
Why?
|
| Receptors, Immunologic | 11 | 2019 | 1423 | 1.130 |
Why?
|
| Confusion | 2 | 2018 | 275 | 1.090 |
Why?
|
| Phagocytes | 4 | 2013 | 297 | 0.850 |
Why?
|
| Phagocytosis | 15 | 2019 | 1539 | 0.840 |
Why?
|
| Scavenger Receptors, Class A | 6 | 2017 | 54 | 0.730 |
Why?
|
| Macrophages | 18 | 2020 | 5655 | 0.720 |
Why?
|
| Receptors, Lipoprotein | 5 | 2002 | 81 | 0.680 |
Why?
|
| Monocytes | 8 | 2020 | 2596 | 0.650 |
Why?
|
| Roseolovirus Infections | 1 | 2018 | 45 | 0.610 |
Why?
|
| Meningoencephalitis | 1 | 2018 | 78 | 0.600 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 95 | 0.600 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 1061 | 0.600 |
Why?
|
| Complement C1q | 2 | 2016 | 92 | 0.580 |
Why?
|
| Adrenoleukodystrophy | 1 | 2017 | 123 | 0.540 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2013 | 1836 | 0.520 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1950 | 0.500 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1431 | 0.450 |
Why?
|
| Cryptococcus neoformans | 3 | 2009 | 119 | 0.440 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.440 |
Why?
|
| Receptors, CCR2 | 3 | 2010 | 212 | 0.440 |
Why?
|
| Astrocytes | 3 | 2017 | 1270 | 0.430 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 847 | 0.430 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3768 | 0.420 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5974 | 0.420 |
Why?
|
| Chemokines | 5 | 2010 | 970 | 0.400 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7880 | 0.400 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 56 | 0.400 |
Why?
|
| Brain | 11 | 2020 | 26385 | 0.390 |
Why?
|
| Triterpenes | 1 | 2011 | 80 | 0.390 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 518 | 0.380 |
Why?
|
| Inflammation | 6 | 2018 | 10638 | 0.380 |
Why?
|
| Models, Immunological | 2 | 2017 | 527 | 0.370 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 8863 | 0.360 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2010 | 675 | 0.360 |
Why?
|
| Glioblastoma | 3 | 2020 | 3481 | 0.360 |
Why?
|
| Mice | 33 | 2020 | 81183 | 0.350 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1620 | 0.340 |
Why?
|
| Parasites | 1 | 2012 | 163 | 0.340 |
Why?
|
| Candida albicans | 2 | 2010 | 394 | 0.340 |
Why?
|
| Fungi | 1 | 2012 | 327 | 0.340 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 157 | 0.340 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2003 | 341 | 0.330 |
Why?
|
| Animals | 43 | 2020 | 168757 | 0.330 |
Why?
|
| Signal Transduction | 11 | 2019 | 23403 | 0.330 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 251 | 0.320 |
Why?
|
| Immune System | 1 | 2013 | 805 | 0.290 |
Why?
|
| Immunity, Innate | 4 | 2017 | 2958 | 0.280 |
Why?
|
| Encephalitis | 1 | 2010 | 423 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4462 | 0.270 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1017 | 0.260 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 2012 | 0.260 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.260 |
Why?
|
| Glioma | 1 | 2020 | 3401 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 14 | 2020 | 21827 | 0.260 |
Why?
|
| Reactive Oxygen Species | 9 | 2016 | 2077 | 0.250 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 9734 | 0.240 |
Why?
|
| Plaque, Amyloid | 3 | 2019 | 729 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.240 |
Why?
|
| Neurons | 3 | 2019 | 9338 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5442 | 0.220 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1477 | 0.220 |
Why?
|
| Oxazolidinones | 1 | 2003 | 96 | 0.220 |
Why?
|
| Vancomycin Resistance | 1 | 2003 | 128 | 0.220 |
Why?
|
| Enterococcus faecium | 1 | 2003 | 102 | 0.220 |
Why?
|
| Cytokines | 6 | 2020 | 7322 | 0.220 |
Why?
|
| Apoptosis | 2 | 2016 | 9727 | 0.210 |
Why?
|
| Caenorhabditis elegans | 2 | 2009 | 1419 | 0.210 |
Why?
|
| Ligands | 6 | 2017 | 3282 | 0.210 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5021 | 0.200 |
Why?
|
| Acetamides | 1 | 2003 | 249 | 0.200 |
Why?
|
| Fallopian Tube Diseases | 1 | 2001 | 62 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 12072 | 0.200 |
Why?
|
| Bacteria | 1 | 2012 | 2114 | 0.190 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 4776 | 0.190 |
Why?
|
| Ovarian Diseases | 1 | 2001 | 139 | 0.180 |
Why?
|
| Mice, Knockout | 11 | 2019 | 14557 | 0.180 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1940 | 0.180 |
Why?
|
| Cell Adhesion | 8 | 2009 | 3144 | 0.180 |
Why?
|
| Cells, Cultured | 12 | 2017 | 19229 | 0.170 |
Why?
|
| Scavenger Receptors, Class B | 5 | 2002 | 81 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2020 | 118 | 0.170 |
Why?
|
| Mucormycosis | 1 | 2020 | 97 | 0.170 |
Why?
|
| Up-Regulation | 4 | 2020 | 4217 | 0.170 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 418 | 0.160 |
Why?
|
| Foscarnet | 1 | 2018 | 38 | 0.160 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1547 | 0.160 |
Why?
|
| Graft vs Host Reaction | 1 | 2018 | 104 | 0.160 |
Why?
|
| Genes, env | 1 | 1997 | 95 | 0.150 |
Why?
|
| Abscess | 1 | 2001 | 607 | 0.150 |
Why?
|
| Moths | 2 | 2010 | 87 | 0.150 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2007 | 41 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 81 | 0.150 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.150 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.150 |
Why?
|
| Disease Progression | 2 | 2015 | 13284 | 0.150 |
Why?
|
| Pseudomonas Infections | 1 | 2001 | 613 | 0.150 |
Why?
|
| Milk Proteins | 1 | 2017 | 169 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 216 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 16689 | 0.140 |
Why?
|
| Distal Myopathies | 1 | 2016 | 16 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2019 | 769 | 0.140 |
Why?
|
| Receptors, Fc | 2 | 1997 | 541 | 0.140 |
Why?
|
| Facial Paralysis | 1 | 2020 | 338 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 972 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18029 | 0.130 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 58 | 0.130 |
Why?
|
| Humans | 41 | 2020 | 744343 | 0.130 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 525 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4204 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1038 | 0.120 |
Why?
|
| Chemokine CCL2 | 2 | 2010 | 617 | 0.120 |
Why?
|
| Autopsy | 1 | 2018 | 1020 | 0.120 |
Why?
|
| Antibodies | 3 | 2017 | 2460 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2020 | 1915 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 804 | 0.120 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 172 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3505 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1341 | 0.120 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 156 | 0.120 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2013 | 16 | 0.120 |
Why?
|
| Cyclic AMP | 1 | 1997 | 1472 | 0.110 |
Why?
|
| Cholesteatoma | 1 | 2013 | 26 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2020 | 795 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2003 | 1139 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1850 | 0.110 |
Why?
|
| Aging | 2 | 2009 | 8664 | 0.110 |
Why?
|
| Endocytosis | 1 | 2017 | 985 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 248 | 0.110 |
Why?
|
| Postmenopause | 1 | 2001 | 2461 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 713 | 0.110 |
Why?
|
| Solubility | 2 | 2013 | 1085 | 0.110 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 669 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1185 | 0.100 |
Why?
|
| Cell Communication | 1 | 2019 | 1621 | 0.100 |
Why?
|
| Actins | 2 | 2007 | 2121 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1881 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2019 | 3752 | 0.100 |
Why?
|
| Cryptococcosis | 2 | 2009 | 101 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2015 | 495 | 0.090 |
Why?
|
| Otitis Media | 1 | 2013 | 277 | 0.090 |
Why?
|
| Neurotoxins | 1 | 2011 | 237 | 0.090 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2009 | 28 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 563 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 2216 | 0.090 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2009 | 97 | 0.090 |
Why?
|
| Collagen | 3 | 1996 | 2689 | 0.090 |
Why?
|
| Candidiasis | 2 | 2010 | 366 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 111 | 0.090 |
Why?
|
| Cricetulus | 1 | 2011 | 816 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1889 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2017 | 1809 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2013 | 635 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2015 | 1349 | 0.080 |
Why?
|
| Cerebellum | 1 | 2016 | 1488 | 0.080 |
Why?
|
| CHO Cells | 1 | 2011 | 1406 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2013 | 1959 | 0.080 |
Why?
|
| Protein Binding | 4 | 2016 | 9386 | 0.080 |
Why?
|
| Temporal Bone | 1 | 2013 | 661 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2007 | 791 | 0.080 |
Why?
|
| Chemokine CXCL9 | 1 | 2008 | 132 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12959 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2013 | 10252 | 0.080 |
Why?
|
| Cricetinae | 1 | 2011 | 2472 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3586 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1999 | 222 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1320 | 0.070 |
Why?
|
| Receptors, CXCR3 | 1 | 2008 | 237 | 0.070 |
Why?
|
| Chemokine CXCL10 | 1 | 2008 | 304 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 5708 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 354 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
| Malaria, Cerebral | 1 | 2008 | 135 | 0.070 |
Why?
|
| Gene Expression | 2 | 2017 | 7799 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 4251 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 565 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2203 | 0.070 |
Why?
|
| Leukotriene B4 | 2 | 1999 | 294 | 0.070 |
Why?
|
| Plasmids | 1 | 2011 | 2307 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2009 | 558 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2018 | 2987 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.060 |
Why?
|
| Fibrin | 2 | 1999 | 506 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2019 | 690 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7186 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2007 | 11366 | 0.060 |
Why?
|
| Proteomics | 1 | 2017 | 3638 | 0.060 |
Why?
|
| Lyme Disease | 1 | 2009 | 621 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2025 | 0.060 |
Why?
|
| Chemotaxis | 2 | 2003 | 607 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2104 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 852 | 0.050 |
Why?
|
| Glucose | 1 | 1994 | 4397 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6770 | 0.050 |
Why?
|
| Peroxides | 1 | 2002 | 74 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2009 | 640 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6365 | 0.050 |
Why?
|
| Male | 8 | 2020 | 350118 | 0.050 |
Why?
|
| Biological Assay | 1 | 2004 | 652 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3521 | 0.050 |
Why?
|
| Tyrosine | 3 | 2007 | 1461 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3079 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10481 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2513 | 0.050 |
Why?
|
| Neutrophils | 3 | 1999 | 3719 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 898 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2003 | 4420 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2004 | 912 | 0.050 |
Why?
|
| Dysarthria | 1 | 2020 | 57 | 0.050 |
Why?
|
| Opsonin Proteins | 1 | 2000 | 150 | 0.040 |
Why?
|
| HIV-1 | 1 | 1997 | 6939 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2000 | 66 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21746 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 91 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1263 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2020 | 175 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 146 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1092 | 0.040 |
Why?
|
| Empathy | 1 | 2003 | 474 | 0.040 |
Why?
|
| Amyloid | 1 | 2003 | 795 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 6314 | 0.040 |
Why?
|
| Cell Line | 3 | 2009 | 15997 | 0.040 |
Why?
|
| Cell Movement | 3 | 2008 | 5217 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 372 | 0.040 |
Why?
|
| Paxillin | 1 | 2007 | 86 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2007 | 86 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2013 | 8436 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18370 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1997 | 290 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1997 | 708 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 442 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 731 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 159 | 0.030 |
Why?
|
| Fetus | 1 | 2002 | 1880 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 176 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 160 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 320 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 271 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 592 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2009 | 5179 | 0.030 |
Why?
|
| Earache | 1 | 2013 | 15 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1994 | 153 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 213383 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1996 | 13815 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1994 | 356 | 0.030 |
Why?
|
| Female | 8 | 2020 | 380194 | 0.030 |
Why?
|
| Rats | 2 | 2002 | 24260 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1994 | 590 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12745 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 159 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1224 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 18111 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 697 | 0.030 |
Why?
|
| Hearing Loss, Conductive | 1 | 2013 | 158 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 480 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.020 |
Why?
|
| Protein Folding | 1 | 2015 | 843 | 0.020 |
Why?
|
| Zymosan | 1 | 1991 | 124 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 489 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2015 | 542 | 0.020 |
Why?
|
| United States | 2 | 2017 | 69872 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 16718 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 571 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6386 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1400 | 0.020 |
Why?
|
| Immunization | 1 | 2015 | 1256 | 0.020 |
Why?
|
| Slovenia | 1 | 2009 | 9 | 0.020 |
Why?
|
| src-Family Kinases | 2 | 2003 | 551 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 72290 | 0.020 |
Why?
|
| Hyphae | 1 | 2010 | 56 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1526 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
| Tuftsin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 826 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3200 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5097 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 719 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3922 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1285 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 645 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 905 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 261 | 0.020 |
Why?
|
| Plasmodium berghei | 1 | 2008 | 168 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2020 | 5985 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2035 | 0.020 |
Why?
|
| Hemocytes | 1 | 2005 | 41 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1616 | 0.020 |
Why?
|
| Headache | 1 | 2013 | 1226 | 0.020 |
Why?
|
| Peptides | 1 | 1996 | 4409 | 0.010 |
Why?
|
| Foam Cells | 1 | 2003 | 71 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20129 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 116 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2009 | 2375 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12788 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2362 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1991 | 2455 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 675 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2133 | 0.010 |
Why?
|
| Virulence | 1 | 2005 | 1333 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1998 | 2187 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8340 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 41006 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 730 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1580 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9648 | 0.010 |
Why?
|
| Scopoletin | 1 | 1998 | 2 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7913 | 0.010 |
Why?
|
| Catalase | 1 | 1998 | 222 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 814 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 163280 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 821 | 0.010 |
Why?
|
| Calcium | 1 | 1991 | 5756 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9146 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1997 | 107 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15540 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 63114 | 0.010 |
Why?
|
| Acetylation | 1 | 1998 | 1085 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 4011 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1157 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2440 | 0.010 |
Why?
|
| Child | 1 | 2003 | 77709 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 85781 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 1994 | 15 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 1888 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 4479 | 0.010 |
Why?
|
| Models, Biological | 2 | 2002 | 9583 | 0.010 |
Why?
|
| Benzoxazoles | 1 | 1994 | 77 | 0.010 |
Why?
|
| Laminin | 1 | 1995 | 419 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3445 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1994 | 367 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1998 | 1053 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1995 | 835 | 0.010 |
Why?
|
| Acridine Orange | 1 | 1991 | 26 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1991 | 39 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1991 | 92 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 57776 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6933 | 0.010 |
Why?
|
| Magnesium | 1 | 1994 | 813 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 148 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1998 | 9274 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 751 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 2025 | 0.000 |
Why?
|
| Time Factors | 2 | 2003 | 40075 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1917 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 56430 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1991 | 2699 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4560 | 0.000 |
Why?
|